Orthofix International | OFIX - Current Liabilities


Orthofix International reported $157.01M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Accuray USD 199.44M 4.83M Dec/2025
AngioDynamics USD 71.96M 3.68M Sep/2025
Artivion USD 76.66M 30.28M Sep/2026
AtriCure USD 83.97M 2.06M Sep/2026
Dexcom USD 2.25B 105.1M Sep/2026
EDAP TMS EUR 37.51M 6.1M Mar/2026
Globus Medical USD 507.94M 28.59M Sep/2026
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 814.4M 70.2M Sep/2026
Integra LifeSciences USD 329M 1.88M Sep/2026
J&J USD 55.46B 562M Sep/2026
Medtronic USD 11.8B 141M Jun/2026
Mesa Laboratories USD 54.4M 6.1M Dec/2025
Orthofix International USD 157.01M 4.02M Jun/2026
Plus Therapeutics USD 8.57M 612K Jun/2026
Smith & Nephew USD 2.05B 510M Jun/2026
STAAR Surgical USD 75.54M 2.15M Sep/2026
Stryker USD 6.5B 184M Sep/2026
Tandem Diabetes Care USD 256.08M 3.07M Sep/2026
Teleflex USD 917.1M 196.72M Sep/2026
Veracyte USD 84.21M 21.47M Sep/2026
Zimmer Biomet Holdings USD 3.5B 488.9M Sep/2026